Intervention

Testosterone

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 23 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials23

Recruiting1

Common conditions25

Lead sponsors shown15

Clinical trials

23 shown

Association Between Human Immunodeficiency Virus (HIV) Infection and Male HypogonadismNCT04760574 · 2021-02-02

Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNCT05773183 · 2023-03-12

Testosterone Regulation of the Natriuretic Peptide SystemNCT02269072 · 2015-02-01

Lifestyle Intervention and Testosterone Replacement in Obese SeniorsNCT02367105 · 2015-02-01

Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.NCT03619330 · 2014-12-01

Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With HypogonadismNCT01084369 · 2013-10-11

Testosterone Antidepressant Augmentation in WomenNCT01783574 · 2013-08-01

Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron TreatmentNCT02111434 · 2013-07-01

Testosterone and Weight LossNCT01616732 · 2013-04-01

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone TherapyNCT01697345 · 2013-02-01

The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) TrialNCT01469988 · 2012-11-01

Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)NCT01560546 · 2012-03-01

Influence of Male Hormones on Regional Fat MetabolismNCT01160328 · 2010-06-01

Testosterone in Castration-Resistant Prostate CancerNCT00577980 · 2007-12-01

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsNCT00497458 · 2007-07-01

Effects of Testosterone in Women With DepressionNCT00676676 · 2007-03-01

Testosterone for Men With Insulin Treated Type 2 DiabetesNCT00349362 · 2006-07-01

Testosterone for Peripheral Vascular DiseaseNCT00504712 · 2006-02-01

Testosterone Replacement in Diabetes With Vascular Disease (Version 2)NCT00355537 · 2006-02-01

Metabolic Effects of Steroids in Obese MenNCT00983554 · 2005-06-01

Testosterone Replacement in Metabolic Syndrome and InflammationNCT01123278 · 2004-01-01

AIDS Wasting in Women: Anabolic Effects of TestosteroneNCT00006158 · 1998-09-01

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal FatNCT00009555

Common conditions

Leading sponsors

Barnsley Hospital 3 Massachusetts General Hospital 3 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 Austin Health 1 Creighton University 1 Gulhane School of Medicine 1 Havah Therapeutics Pty Ltd 1 M.D. Anderson Cancer Center 1 Marianne Andersen 1 Mayo Clinic 1 National Institute of Allergy and Infectious Diseases (NIAID) 1 National Taiwan University Hospital 1 Royal College of Surgeons, Ireland 1 Tameside Hospital NHS Foundation Trust 1 University Medical Centre Ljubljana 1

Trial status mix

COMPLETED15

UNKNOWN3

TERMINATED2

WITHDRAWN2

RECRUITING1

Phase mix

PHASE49

PHASE25

NA4

EARLY_PHASE11

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.